Six years ago Abiraterone was hailed as a medical breakthrough that could offer men extra time with loved ones and a chance to delay chemotherapy and its debilitating side effects.
Today the body that recommends what can and cannot be paid for said it 'wasn't cost effective'.
Prostate cancer patients have now been told that the life-extending drug will not be routinely prescribed unless they have chemotherapy.
One man from North Yorkshire who is fighting prostate cancer is calling for a rethink:
More top news
The remains of Hurricane Gonzalo will reach the UK on Monday night, bringing a period of strong winds and heavy rain to the UK.
An unsettled week with showers or rain and some very strong winds. There's a Met Office warning for gales as we head into Tuesday
Very windy today with gusts of 55mph, but nearer 70mph over the tops of the Pennines. Trans-Pennine routes could be treacherous